Clinical Trials · NCT01715129
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ipsen
- Enrollment
- 126
- Start date
- Jan 2013
- Locations
- 12 sites, 5 countries
- Primary endpoint
- Percentage of Subjects Demonstrating Castration at Day 29 and Maintaining Castration at Day 183